PREDNICARBATE Drug Patent Profile
✉ Email this page to a colleague
When do Prednicarbate patents expire, and what generic alternatives are available?
Prednicarbate is a drug marketed by Fougera Pharms and is included in two NDAs.
The generic ingredient in PREDNICARBATE is prednicarbate. There is one drug master file entry for this compound. Additional details are available on the prednicarbate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prednicarbate
A generic version of PREDNICARBATE was approved as prednicarbate by FOUGERA PHARMS on March 9th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PREDNICARBATE?
- What are the global sales for PREDNICARBATE?
- What is Average Wholesale Price for PREDNICARBATE?
Summary for PREDNICARBATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,355 |
| Drug Prices: | Drug price information for PREDNICARBATE |
| What excipients (inactive ingredients) are in PREDNICARBATE? | PREDNICARBATE excipients list |
| DailyMed Link: | PREDNICARBATE at DailyMed |
Recent Clinical Trials for PREDNICARBATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Handok Pharmaceuticals Co., Ltd. | Phase 4 |
| Handok Inc. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for PREDNICARBATE
US Patents and Regulatory Information for PREDNICARBATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | PREDNICARBATE | prednicarbate | CREAM;TOPICAL | 077287-001 | Sep 19, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fougera Pharms | PREDNICARBATE | prednicarbate | OINTMENT;TOPICAL | 077236-001 | Mar 9, 2007 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
